| AJCR Copyright © 2010-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA |
Forthcoming Titles
(PDFs in this page may have not been proofed yet)
Volume 2, Issue 2;2012
Xuguang Zhu, Sheue-yann Cheng: Modeling follicular thyroid cancer for future therapies. Am J Cancer Res 2012;2(2):130-140. (Abstract,
0000100, full text PDF).
Eiji Takaoka, Hiroshi Sonobe, Kunihiro Akimaru, Shuji Sakamoto, Taro Shuin, Masanori Daibata, Takahiro Taguchi, Akira Tominaga: Multiple
sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell
line. Am J Cancer Res 2012;2(2):141-152. (Abstract, 0000107, full text PDF).
Yuri Sheikine, Elizabeth Genega, Jonathan Melamed, Peng Lee, Victor E. Reuter, Huihui Ye: Molecular genetics of testicular germ cell tumors.
Am J Cancer Res 2012;2(2):153-167.(Abstract, 0000104, full text PDF).
Christina Pettan-Brewer, John Morton, Sarah Cullen , Linda Enns, Keffy R.M. Kehrli, Julia Sidorova, Jorming Goh, Rebecca Coil, Warren C.
Ladiges: Tumor growth is suppressed in mice expressing a truncated XRCC1 rotein. Am J Cancer Res 2012;2(2):168-177. (Abstract, 0000101,
full text PDF).
Ali R Jazirehi, Peter B Wenn, Mohsen Damavand: Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in
melanoma therapy. Am J Cancer Res 2012;2(2):178-191. (Abstract, 0000096, full text PDF).
Manawapat A, Stubenrauch F, Russ R, Munk C, Kjær SK, Iftner T: Physical state and viral load as predictive biomarkers for persistence and
progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study. Am J Cancer Res 2012;2(2):
192-203. (Abstract, 0000095, full text PDF).
Charles F. Babbs: Predicting success or failure of immunotherapy for cancer: insights from a clinically applicable mathematical model. Am J
Cancer Res 2012;2(2):204-213. (Abstract, 0000097, full text PDF).
Rebecca T. Marquez, Liang Xu: Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res
2012;2(2):214-221. (Abstract, 0000098, full text PDF).
Najmunnisa Nasreen, Nazli Khodayari, Kamal A: Mohammed: Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel
approach. Am J Cancer Res 2012;2(2):222-234. (Abstract, 0000102, full text PDF).
Danilo Swann Matassa, Maria Rosaria Amoroso, Francesca Maddalena, Matteo Landriscina, Franca Esposito: New insights into TRAP1
pathway. Am J Cancer Res 2012;2(2):235-248. (Abstract, 0000108, full text PDF).
Ichiro Yajima, Mayuko Y Kumasaka, Yuji Naito, Toshikazu Yoshikawa, Hiro Takahashi, Yoko Funasaka, Tamio Suzuki, Masashi Kato: Reduced
GNG2 expression levels in mouse and human malignant melanomas. Am J Cancer Res 2012;2(x):xx-xx.(Abstract, 0000105, full text PDF).
Amy C. Sievers, Joseph H. Antin: Post-transplant lymphoproliferative disorders, a review. Am J Cancer Res 2012;2(x):xx-xx.
Tanya Kalin, et al: Signaling pathways regulated by FoxM1 oncogene in lung cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ann Richmond, et al: Interrelationship between aurora kinaseA and inhibitor of kappa-beta kinase (IKK) inhibition in melanoma. Am J Cancer
Res 2012;2(x):xx-xx.
Stephen A. Boppart, et al: Ultrastructural changes during tumor development detected by polarization-sensitivie optical coherence tomography.
Am J Cancer Res 2012;2(x):xx-xx.
Franca Esposito, et al: New insights into the TRAP1 pathway. Am J Cancer Res 2012;2(x):xx-xx.
Jenny Wang, et al: TGFb-mediated suppression of metastasis in colon cancer. Am J Cancer Res 2012;2(x):xx-xx.
Dan A. Liebermann, et al: Gadd45 family of genes sensors of i oncogenic stress. Am J Cancer Res 2012;2(x):xx-xx.
Bharat B. Aggarwal, et al: Inflammation and cancer: a story of association and dissociation. Am J Cancer Res 2012;2(x):xx-xx.
Michael A. Tainsky, et al: Innate immunity in cancer development. Am J Cancer Res 2012;2(x):xx-xx.
Elizabeth Moran, et al: Molecular role of the retinoblastoma family in suppression of osteosarcoma, and in control of normal osteoblast
differentiation. Am J Cancer Res 2012;2(x):xx-xx.
Jong-Wan Park, et al: Does HIF promote or demote skin cancer? Am J Cancer Res 2012;2(x):xx-xx.
Asit K. De, et al: Role of heat shock protein 27 in human cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hyeong-Reh Choi Kim, et al: A novel mechanism of PDGF signaling in human cancer. Am J Cancer Res 2012;2(x):xx-xx.
Elizabeth M. Wilson, et al: Androgen receptor action in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
François E. Paris, et al: Ionizing radiation induces acute and long terms responses in endothelial cells. Am J Cancer Res 2012;2(x):xx-xx.
Dmitry Pshezhetskiy, et al: Bacterial infection mediates prostate cancer progression through activation of sphingosine kinase 1. Am J Cancer
Res 2012;2(x):xx-xx.
Xiang-ping Li, et al: Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Am J Cancer Res
2012;2(x):xx-xx.
Franceca Ricci, Massimo Broggini, Giovanna Damia: Tumor initianting cell of ovarian cancer. Am J Cancer Res 2012;2(x):xx-xx.
Chiun Hsu, et al: "off-target" effects of sorafenib for the treatment of hepatocellular carcinoma: translational and clinical implications. Am J Cancer
Res 2012;2(x):xx-xx.
Gopal C. Kundu, et al: Osteopontin, a potentially important therapeutic target in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Stephen H. Thorne, et al: Combining biological therapies for optimal treatment of cancer. Am J Cancer Res 2012;2(x):xx-xx.
Patrick Pollard, et al: Metabolic biomarkers: a new era in cancer identification and stratification. Am J Cancer Res 2012;2(x):xx-xx.
Olivier Cuvillier, et al: Sphingosine 1-phosphate, a cancer therapeutic target. Am J Cancer Res 2012;2(x):xx-xx.
Stephanie Ma, et al: microRNA regulation in cancer stem cells. Am J Cancer Res 2012;2(x):xx-xx.
Dina Allam, Leo K. Iwai, Paul H. Huang: Discoidin domain receptor signalling networks in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Mong-Hong Lee, et al: Role of 14.33 sigma in DNA damage response. Am J Cancer Res 2012;2(x):xx-xx.
Qiuyin Cai, et al: Mitochondrial DNA variations with breast cancer risk and outcome. Am J Cancer Res 2012;2(x):xx-xx.
Jacques E. Nor, et al: Stem cells in salivary gland cancer. Am J Cancer Res 2012;2(x):xx-xx.
James A. Koziol, Zhenyu Jia, Michael B. Lilly, Dan A. Mercola: The use of nomogram predictions as comparators for adjuvant treatment studies
in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Durga Udayakumar, Hensin Tsao: Role of Eph Receptors in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Fahd Al-Mulla, et al: RKIP interacts with KEAP1 to promote chemotherapeutic resistance. Am J Cancer Res 2012;2(x):xx-xx.
Yangbing Zhao, et al: Influence of T cell stimulation on anti-tumor activities of RNA electroporated T cells. Am J Cancer Res 2012;2(x):xx-xx.
Fahd Al-Mulla, et al: Chromothripsis in colorectal cancer. Am J Cancer Res 2012;2(x):xx-xx.
Mei-Yi Lee, Cheng-Yang Chou, Meng-Ru Shen: Epithelial-mesenchymal transition in cervical cancer. Am J Cancer Res 2012;2(x):xx-xx.
Zanella F, García B, Callejas S, Peregrina S, Carnero A, Wolfgang Link: Chemical genetic rescue profiling for target deconvolution. Am J Cancer
Res 2012;2(x):xx-xx.
Zhenyu Jia, Yipeng Wang, Kai Ye, Xiao-Qin Xia, Yuanjie Hu, Hui Li, Sha Tang, Waldemar Lernhardt, James A. Koziol, Michael McClelland, Dan
Mercola: Increasing sample size does not boost power if confounding factors are not controlled – a study of prostate cancer expression profiles.
Am J Cancer Res 2012;2(x):xx-xx.
Daniel Monleon, et al: Cancer metabolism beyond the Warburg effect. Am J Cancer Res 2012;2(x):xx-xx.
Guido Kroemer: Autophagic cell death in cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Claudio Sorio, et al: Applications of Fourier transformed microspectroscopy in cancer research. Am J Cancer Res 2012;2(x):xx-xx.
Samir Iqbal, et al: Nanotechnology for cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hinrich Gronemeyer: Epigenetic regulation of cancer-selective TRAIL-mediated apoptosis. Am J Cancer Res 2012;2(x):xx-xx.
Margaret A. Knowles: Preclinical models for bladder cancer. Am J Cancer Res 2012;2(x):xx-xx.
Subbaya Subramanian, et al: MicroRNA gene regulatory newtorks in sarcomas. Am J Cancer Res 2012;2(x):xx-xx.
Maurizio D’Incalci, et al: Mechanism of action of marine natural products with antitumor properties. Am J Cancer Res 2012;2(x):xx-xx.
Lucio Miele, et al: Notch signaling in breast cancer: context dependence and therapeutic targeting. Am J Cancer Res 2012;2(x):xx-xx.
Max Costa, et al: Histone tail modifications and Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ali Jazirehi, et al: Bortezomib for the treatment of melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Donald J. Johann, et al: Advancing molecular profiling with mass spectrometry based clinical proteomics. Am J Cancer Res 2012;2(x):xx-xx.
Michael L. Freeman, et al: Repression of Nrf2 signaling. Am J Cancer Res 2012;2(x):xx-xx.
Michael J. Seckl, et al: Targeting the JAK/STAT signalling pathway in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Andrew E. Aplin, et al: FOXD3 regulation of migration in melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Thomas Helleday: The synthetic lethal concept for novel cancer treatments: potentials and pitfalls. Am J Cancer Res 2012;2(x):xx-xx.
Vincent L. Cryns: Molecular chaperones and cancer. Am J Cancer Res 2012;2(x):xx-xx.
Francois X. Claret, et al: Evolving Strategies for treatment of HER2-positive breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Alfredo Fusco, et al: RNA and microRNA expression profile in pituitary adenomas. Am J Cancer Res 2012;2(x):xx-xx.
Su Hao Lo, et al: The dual roles of cten in tumorigenesis. Am J Cancer Res 2012;2(x):xx-xx.
Ben Ho Park: Androgen receptor as a targeted therapy for breast cancer (mini-review). Am J Cancer Res 2012;2(x):xx-xx.
Philip Hahnfeldt, et al: Intercellular interactions as a modulator of carcinogenesis and cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Markus H. Frank, et al: Role of ABCB5 in cancer multidrug resistance. Am J Cancer Res 2012;2(x):xx-xx.
Tohru Kiyono, et al: An in vitro multistep carcinogenesis model for both HPV- positive and -negative human oral squamous cell carcinoma. Am J
Cancer Res 2012;2(x):xx-xx.
Ratna K. Vadlamudi, et al: MicroRNA signaling in breast cancer: novel therapeutics. Am J Cancer Res 2012;2(x):xx-xx.
David M. Owens, et al: Dissecting the role of CD200 signaling in tumor progression and metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Balakrishna L. Lokeshwar, et al: Spicing up anticancer medicine: time to seriously consider dietary anticancer compounds in cancer therapy. Am
J Cancer Res 2012;2(x):xx-xx.
Shanaz H. Dairkee, et al: Novel cancer models to assist in oncogenic pathway identification. Am J Cancer Res 2012;2(x):xx-xx.
Gutian Xiao, et al: Negative regulation of NF-kappaB in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Paul Szabolcs, et al: Challenges and opportunities: immune reconstitution after cord blood transplantation. Am J Cancer Res 2012;2(x):xx-xx.
Zdenko Herceg, et al: Epigenetic mechanisms, stem cells and cancer (review). Am J Cancer Res 2012;2(x):xx-xx.
Venuprasad K. Poojary, et al: TGF-beta and regulation of anti-tumor immune response. Am J Cancer Res 2012;2(x):xx-xx.
Shi-Yong Sun, et al: Impact of genetic alterations on mTOR-targeted cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Othon Iliopoulos, et al: HIF2a as a therapeutic target for cancer angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Hari K Koul, et al: Tetrandrine targets cell cycle to inhibit prostate cancer growth. Am J Cancer Res 2012;2(x):xx-xx.
Godefridus J. Peters, et al: Translation of animal models to the patient; why do they not always work? Am J Cancer Res 2012;2(x):xx-xx.
Ester Hammond, et al: DNA damage signalling in hypoxia. Am J Cancer Res 2012;2(x):xx-xx.
Jiaoti Huang, et al: Cell origin for prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Shuichi Kaneko, et al: Stem cells of hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Bo Huang, et al: Mast cells: toward the road of remodeling tumor microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Haval Shirwan: Cancer vaccines, an update. Am J Cancer Res 2012;2(x):xx-xx.
Masamitsu Yamaguchi, et al: Regulation of Hippo pathway genes by DRE/DREF system. Am J Cancer Res 2012;2(x):xx-xx.
Karim Nayernia, et al: PhD,Cancer stem cells: a new approaches for diagnostics and therapy. Am J Cancer Res 2012;2(x):xx-xx.
Matthew L. Anderson: MicroRNAs in gynecologic cancer. Am J Cancer Res 2012;2(x):xx-xx.
M.R. Satyanarayana Rao, et al: Molecular and Cellular heterogeneity of Glioma. Am J Cancer Res 2012;2(x):xx-xx.
Qian Zheng, et al: Can chemotherapy be individualized in prostate cancer? Am J Cancer Res 2012;2(x):xx-xx.
Pablo Menendez, et al: Modelling sarcomas using MSCs. Am J Cancer Res 2012;2(x):xx-xx.
Kosaku Iwatsubo, et al: Epac1 as a mediator of melanoma metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Sam Thiagalingam, et al: Epigenetic regulation of breast cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Christopher H. Parsons, et al: SHV interactions with the cell surface: new paradigms for HIV-associated cancer pathogenesis and the
development of novel therapeutic approaches. Am J Cancer Res 2012;2(x):xx-xx.
Yuval Shaked, et al: The role of bone marrow derived cells in tumor angiogenesis and growth. Am J Cancer Res 2012;2(x):xx-xx.
Irina Nazarenko, et al: Different modes of intercellular communication and their impact on tumour progression. Am J Cancer Res 2012;2(x):xx-xx.
Anjali Jain, et al: Targeting mTOR in PTEN-null NSCLC after acquired resistance to EGFR-TKIs. Am J Cancer Res 2012;2(x):xx-xx.
François Ghiringhelli: Targeting myeloid derived suppressor cells to relieve tumor induce immunosuppression. Am J Cancer Res 2012;2(x):xx-xx.
Mark W Jackson, et al: Defining novel tumor suppressor-oncogene interactions in mammary cell transformation. Am J Cancer Res 2012;2(x):xx-
xx.
Wenxing Zheng, et al: Secretory cells of fallopian tube as the main source for female pelvic serous carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Sandra Orsulic, et al: Expression of HOXB13 in adult human tissues and its relevance to cancer. Am J Cancer Res 2012;2(x):xx-xx.
Jeanette H.W. Leusen, et al: Mechanisms of antibody therapy for cancer. Am J Cancer Res 2012;2(x):xx-xx.
Stephen Safe, et al: The effects of some anticancer drugs on growth inhibition and Sp transcription factor downregulation in cancer. Am J Cancer
Res 2012;2(x):xx-xx.
Prahlad T. Ram, et al: Signaling and mutations in RTK and GPCR networks in melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Qi Dai, et al: Major contributors to isoprotane metabolite, an accurate biomarker for oxidative stress. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Marc A. Lobaccaro, et al: Cholesterol, prostate cancer and LXR: the good, the bad and the ugly. Am J Cancer Res 2012;2(x):xx-xx.
Eitan Shaulian, et al: New mechanisms and target mediating AP-1 activity in transformation. Am J Cancer Res 2012;2(x):xx-xx.
Guojun Wu, et al: EMT and metastatic breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Franco Capozza, et al: Caveolae/Caveolins in skin cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Devanand Sarkar, et al: The transcription factor LSF: a novel oncogene for hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Bin Zhang, et al: Overcoming CD39/CD73-mediated cancer immune evasion. Am J Cancer Res 2012;2(x):xx-xx.
Sandro De Falco, et al: Over-expression of a PlGF2 variant in tumor cells inhibits VEGF-dependent tumor angiogenesis. Am J Cancer Res 2012;2
(x):xx-xx.
Taro Yamashita, et al: Molecular pathogenesis of hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Bin Guo, et al: Regulation of histone methylation by cancer chemopreventive agents. Am J Cancer Res 2012;2(x):xx-xx.
Michael Ohh, et al: Molecular pathobiology of von Hippel-Lindau disease. Am J Cancer Res 2012;2(x):xx-xx.
Sean Bong Lee, et al: Wnt Signaling Pathway and Wilms Tumor. Am J Cancer Res 2012;2(x):xx-xx.
R. Daniel Bonfil, et al: Mechanisms of prostate cancer bone metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Fei Chen, et al: Does apoptosis facilitate carcinogenesis? Am J Cancer Res 2012;2(x):xx-xx.
G. Steven Bova, et al: Why integrated clinical-molecular autopsy studies are critical to future advances in personalized medicine. Am J Cancer
Res 2012;2(x):xx-xx.
Tom Luedde, et al: Inflammatory signaling pathways in hepatocarcinogenesis: From Mouse models to new therapeutic strategies? Am J Cancer
Res 2012;2(x):xx-xx.
Arnold Chin, et al: Toll-like Receptors in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ignacio Perez-Roger, et al: proteasome inhibitors in leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Ceshi Chen, et al: The Hippo tumor suppressor pathway and breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Martin Dutertre, et al: The emerging role of RNA-binding proteins in oncogenesis and stress responses. Am J Cancer Res 2012;2(x):xx-xx.
Kyu-Won Kim, et al: Roles of ARD1 variants in tumor-angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Olivier Gires, et al: Cancer stem cell markers and their respective functions. Am J Cancer Res 2012;2(x):xx-xx.
Fahri Saatcioglu, et al: Regulation of apoptosis in prostate cancer cells by androgens (review). Am J Cancer Res 2012;2(x):xx-xx.
Cristiano Ferlini, et al: Cytoskeletal driven mechanisms of drug resistance in solid tumors. Am J Cancer Res 2012;2(x):xx-xx.
Ramana Davuluri, et al: Alternative promoter genes in development and cancer. Am J Cancer Res 2012;2(x):xx-xx.
Yin-Yuan Mo, et al: Role of tumor suppressive microRNAs in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ajay Goel, et al: Cancer chemoprevention by dietary agents. Am J Cancer Res 2011;1(1):xx-xx. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Ehrland Ricci, et al: Metabolic control of cell deaths. Am J Cancer Res 2012;2(x):xx-xx.
Kiyoshi Ariizumi, et al: The role of co-inhibitory receptors in suppression of anti-tumor T cells by melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Jianhua Luo, et al: Integrin and malignancies. Am J Cancer Res 2012;2(x):xx-xx.
Jörg Wischhusen, et al: Immunological characteristics of cancer stem cells - what do we know? Am J Cancer Res 2012;2(x):xx-xx..
Yoh Takuwa, et al: Role of the lysophospholipid mediator sphingosine-1-phosphate in tumor angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Yaacov Ben-David, et al: The role of transcription factor Fli-1 in development and malignant transformation. Am J Cancer Res 2012;2(x):xx-xx.
Rozita Bagheri-Yarmand, et al: The transcription factor ATF4: a novel tumor suppressor gene in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Yun Wu, et al: Neuroendocrine carcinomas of the breast are resistant to neoadjuvant chemotherapy. Am J Cancer Res 2012;2(x):xx-xx.
Stéphan Vagner, et al: mRNA 3' end heterogeneity in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Jae-Hong Kim, et al: BLT2, a low-affinity receptor for leukotriene B4, is associated with paclitaxel resistance in breast MCF7/ADR cells. Am J
Cancer Res 2012;2(x):xx-xx.
Yong-Jie Lu, et al: Chromosome rearrangement associated inactivation of tumor suppressor genes in prostate cancer. Am J Cancer Res 2012;2
(x):xx-xx.
Keshav Singh, et al: InterGenomic cross talk and its role in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Gareth Inman, et al: Targeting BMP signaling for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Gareth Inman, et al: Smad activation in Ovarian Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Wei Du, et al: Rb, E2F proteins and cellular stress. Am J Cancer Res 2012;2(x):xx-xx.
Shazib Pervaiz, et al: Redox regulation of cell fate in cancer cells. Am J Cancer Res 2012;2(x):xx-xx.
Zhihua Liu, et al: S100 protein family and cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hongchuan Jin, et al: Epigenetic silencing of KL in gastric cancer. Am J Cancer Res 2012;2(x):xx-xx.
Eldad Zacksenhaus, et al: Cancer stem cells at single cell resolution. Am J Cancer Res 2012;2(x):xx-xx.
Mathias Chamaillard, et al: Licensing intestinal homeostasis and tumorigenesis by the inflammasome. Am J Cancer Res 2012;2(x):xx-xx.
Federica Cavallo, et al: Oncoantigens for the immunological prevention of cancer. Am J Cancer Res 2012;2(x):xx-xx.
Roberto Chiarle, et al: Anaplastic Lymphoma Kinase and oncogenic signals in tumors. Am J Cancer Res 2012;2(x):xx-xx.
Xin-yuan Guan, et al: Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in
hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Mohamed El-Tanani, et al: Genetic regulation of human breast cancer metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Gudrun Koehl, et al: Can mTOR inhibition prevent tumor progression or is it only slowing tumor growth? Am J Cancer Res 2012;2(x):xx-xx.
Torben F. Orntoft, et al: Molecular biomarkers for bladder cancer, the use of combined parameters for disease course prediction. Am J Cancer
Res 2012;2(x):xx-xx.
Roberto Diaz, et al: Radiation-Induced Neoantigens: Imaging and Therapeutic Implications. Am J Cancer Res 2012;2(x):xx-xx.
A. Postigo, et al: ZEB proteins as key regulators of cancer stem cells and tumor invasiveness and metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Chenguang Wang, et al: Cyclin D1 regulation of gene transcription. Am J Cancer Res 2012;2(x):xx-xx.
Preet M. Chaudhary, et al: KSHV vFLIP induced genes is primary effusion lymphoma. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Baptiste Vincourt, et al: Consequences of Outside-In Signaling: a matter of ECM integrity. Am J Cancer Res 2012;2(x):xx-xx.
Yong Liao, et al: Oncogenic phophatase Wip1 as a therapeutic target for chemosensitization in human breast cancer. Am J Cancer Res 2012;2(x):
xx-xx.
Yong Liao, et al: Nuclear reprogramming and oncogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Baptiste Vincourt, et al: TGF-receptor independent modulation of Smad signaling by procollagen propeptides. Am J Cancer Res 2012;2(x):
xx-xx.
Grigory Dianov, et al: Targeting base excision repair for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Lucia Altucci, et al: The Epigenome of cancer: a new era for targets and therapy. Am J Cancer Res 2012;2(x):xx-xx.
Christophe Cazaux, et al: Misregulation of genes involved in DNA repair and DNA damage checkpoint confers a poor prognosis in breast cancer
patients. Am J Cancer Res 2012;2(x):xx-xx.
Namhoon Cho, et al: miRNA regulation to affect hormonal refractory prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Giovanni Melillo, et al: Targeting the hypoxic tumor microenvironment for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Thomas Reinheckel, et al: Cysteine cathepsins as targets for cancer therapy: lessons from mouse models. Am J Cancer Res 2012;2(x):xx-xx.
Simone Fulda, et al: Targeting apoptosis signaling for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
David “Neil” Hayes, et al: The Genomics of Lung Cancer and its role in clinical practice, biomarkers, and model systems. Am J Cancer Res 2012;
2(x):xx-xx.
Peter Shaw, et al: Dynamic and interactive properties of ETS transcription factors linked to tumor development. Am J Cancer Res 2012;2(x):xx-xx.
Habib Boukerche, et al: MDA-9/syntenin, angiogenesis and tumor progression. Am J Cancer Res 2012;2(x):xx-xx.
Shigeomi Shimizu, et al: Molecular mechanisms of alternative autophagy. Am J Cancer Res 2012;2(x):xx-xx.
Thomas Iftner, et al: Physical state and viral load as predictive biomarkers for persistence and progression of high risk HPV-infected cervical
lesions: data from a population based prospective cohort follow up of 8656 women for 12 years. Am J Cancer Res 2012;2(x):xx-xx.
Nicholas A Saunders, et al: molecular targeted therapies and traditional chemotherapeutics: what will be best for patients. Am J Cancer Res
2012;2(x):xx-xx.
Stephen T.C. Wong, et al: New systems biology approach for cancer drug repositioning and combination. Am J Cancer Res 2012;2(x):xx-xx.
Ahmed Ashour Ahmed, et al: Aiming at a moving target: targeting mitosis in canccer. Am J Cancer Res 2012;2(x):xx-xx.
Eva M. Harth, et al: Tumor regression of non-small lung cancer with targeted nanosponge delivery system. Am J Cancer Res 2012;2(x):xx-xx.
Sebastien Jauliac, et al: NFAT and cancer: the Ying and the Yang. Am J Cancer Res 2012;2(x):xx-xx.
Jose L. Yelamos, et al: PARP proteins: New players in tumours development. Am J Cancer Res 2012;2(x):xx-xx.
Dosik Min, et al: Regulation of Phospholipase D expression in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Aart Jochemsen, et al: The regulation and functions of MDMX. Am J Cancer Res 2012;2(x):xx-xx.
Michael Hsiao, et al: Platform development for high-throughput identifications and validations of novel tumor-associate genes. Am J Cancer Res
2012;2(x):xx-xx.
Albert S Mellick, et al: Small RNAs and bone marrow mediated tumour vascularisation. Am J Cancer Res 2012;2(x):xx-xx.
Albert S Mellick, et al: Endothelial progenitor cells and clinical course and late stage cancer. Am J Cancer Res 2012;2(x):xx-xx.
Gary W. Reuther, et al: Recent advances in JAK2 function in myeloproliferative neoplasms. Am J Cancer Res 2012;2(x):xx-xx.
Pierre Laurent-Puig, et al: EGFR mutated lung cancers a specific disease? Am J Cancer Res 2012;2(x):xx-xx.
Serge Roche, et al: Src family tyrosine kinase signalling in advanced colon carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Horng-Mo Lee, et al: Nodal is a key molecular switch in regulating aerobic glycolysis in human glioma cells. Am J Cancer Res 2012;2(x):xx-xx.
Nelson Dusetti, et al: TP53INP1 a tumor suppressor gene early disrupted in digestive tract cancerogenesis. Am J Cancer Res 2012;2(x):xx-xx.
David J. MacEwan, et al: MicroRNAs as a new therapeutic target for leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Peter Igaz, et al: Novel aspects of adrenocortical and adrenomedullary tumorigenesis. Am J Cancer Res 2012;2(x):xx-xx.
David Bates, et al: Mechanisms of lymphatic metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Raymond L. Stallings, et al: The role of microRNAs in pediatric cancers. Am J Cancer Res 2012;2(x):xx-xx.
Francoise Redini, et al: How can the micro-environment influence primary bone tumor progression. Am J Cancer Res 2012;2(x):xx-xx.
Andreas G. Bader, et al: Development of microRNA therapeutics. Am J Cancer Res 2012;2(x):xx-xx.
Carlo Gambacorti-Passerini, et al: The development of imatinib for Chronic Myeloid Leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Chang-Deng Hu, et al., ATF2: subcellular localization and oncogenic activity. Am J Cancer Res 2012;2(x):xx-xx.
Fuyu Tamanoi: Mesoporous silica nanoparticles as a delivery system for anticancer drugs and siRNA. Am J Cancer Res 2012;2(x):xx-xx.
Maria Kavallaris, et al: Aurora Kinase Inhibitors in Cancer Therapy. Am J Cancer Res 2012;2(x):xx-xx.
Victoria Cowling, et al: The role of the 7-methylguanosine cap in tumours. Am J Cancer Res 2012;2(x):xx-xx.
Valeria Poli, et al: Stat3 and cancer: dangerous liaisons at multiple levels. Am J Cancer Res 2012;2(x):xx-xx.
Lisa D. Belmont, et al: Pre-clinical models identify predictive biomarkers for the combination of a Bcl-2/Bcl-xL inhibitor and paclitaxel in ovarian
cancer. Am J Cancer Res 2012;2(x):xx-xx.
Weinong Han, Mei Ming, and Yu-Ying He: Sensitization of apoptosis of keratinocytes in response to ultraviolet damage. Am J Cancer Res 2012;2
(x):xx-xx.
Najmunnisa Nasreen, Nazli Khodayari, Kamal A. Mohammed: Advances in malignant mesothelioma therapy: targeting EphA2 - a novel approach.
Am J Cancer Res 2012;2(x):xx-xx.
Ralph Wasch, et al: Cell cycle regulation in acute leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Alain Piche, et al: Death receptors and ovarian cancer: The TRAILs of resistance. Am J Cancer Res 2012;2(x):xx-xx.
John A. Copland, et al: Novel molecular targets for therapy in renal cell carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
John A. Copland, et al: Foxo3a as a novel target for therapy. Am J Cancer Res 2012;2(x):xx-xx.
Nathalie Andrieu-Abadie, et al: Ceramide and Bcl-2 family members in cancer cell signaling. Am J Cancer Res 2012;2(x):xx-xx.
Jeniffer Y. Zhang, et al: Differential roles of JNK or (AP1 proteins) in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Claudio Brancolini, et al: Class IIA HDAC in the control of cell proliferation. Am J Cancer Res 2012;2(x):xx-xx.
Brigitte N. Gomperts, et al: Stem cells in lung cancer. Am J Cancer Res 2012;2(x):xx-xx.
Kairbaan Hodivala-Dilke: Tumour angiogenesis and new insights. Am J Cancer Res 2012;2(x):xx-xx.
Lesley Stark, et al: Nucleolar translocation of NF-kappaB/RelA in the anti-cancer effects of non-steroidal anti-inflammatory drugs. Am J Cancer
Res 2012;2(x):xx-xx.
Annie Huang, et al: Myc - a recurrent problem in medulloblastoma. Am J Cancer Res 2012;2(x):xx-xx.
Irina Nazarenko, et al: A comparative analysis of the binding capacity of tumour-derived exosomes to their target cells: impact of receptor-ligand
interactions. Am J Cancer Res 2012;2(x):xx-xx.
Kirsten Ness, et al: Disability and social isolation in adult survivors of childhood brain tumors. Am J Cancer Res 2012;2(x):xx-xx.
Kirsten Ness, et al: Musculoskeletal late effects in childhood cancer survivors. Am J Cancer Res 2012;2(x):xx-xx.
Deng-Shun Wang, et al: DH-PH domain-containing proteins and human cancer. Am J Cancer Res 2012;2(x):xx-xx.
Farbod Shojaei, et al: identification of biomarkers of resistance to angiogenic inhibitors. Am J Cancer Res 2012;2(x):xx-xx.
Monique A. Spillman, et al: ETV4 is differentially regulated by estrogen in breast cancer cells versus ovarian cancer cells. Am J Cancer Res 2012;
2(x):xx-xx.
Vincent Giguère, et al: Estrogen-related receptors in breast cancer: at the crossroad of estrogen and HER-2 signalling. Am J Cancer Res 2012;2
(x):xx-xx.
Simon Saule, et al: Akirin2 increased expression correlates with survival in metastatic uveal melanoma patients. Am J Cancer Res 2012;2(x):xx-
xx.
Aleksander S. Popel, et al: Computational models of antiangiogenic therapies in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Zong Sheng Guo, et al: Cancer epigenetics and therapeutic implications. Am J Cancer Res 2012;2(x):xx-xx.
Hongwu Chen, et al: Epigenetic regulator networks in cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Jaydutt V. Vadgama, et al: Obesity and Breast Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Laura Bracci, et al: Rationale for efficient combination of chemotherapy and immunotherapy against cancer. Am J Cancer Res 2012;2(x):xx-xx.
Jaydutt V. Vadgama, et al: Role of FOXO1A in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Wenzheng Zhang, et al: Epigenetics of breast cancer and chronic kidney disease. Am J Cancer Res 2012;2(x):xx-xx.
Pranela Rameshwar, et al: AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast
cancer cells. Am J Cancer Res 2012;2(x):xx-xx.
Ben Wielockx, et al: HIF prolyl hydroxylases and their intriguing role during tumor development. Am J Cancer Res 2012;2(x):xx-xx.
Hiroshi Nakagawa, et al: Hypoxia regulates insulin-like growth factor binding protein 3 in esophageal squamous cell carcinoma. Am J Cancer
Res 2012;2(x):xx-xx.
Keiran S. Smalley, et al: Therapeutic targeting of BRAF wild-type melanoma. Am J Cancer Res 2012;2(x):xx-xx.
John Lynch, et al: The role for autophagy in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Am J Cancer Res 2012;2
(x):xx-xx.
Joaquín V. Arribas López, et al: Signaling by HER2 fragments. Am J Cancer Res 2012;2(x):xx-xx.
Wei Xu, et al: Recent advance in protein O-glycosylation in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Rajgopal Govindarajan, et al: Pancreatic cancer chemotherapy: progress and future. Am J Cancer Res 2012;2(x):xx-xx.
Hava Gil-Henn, et al: Invadopodia put the foot in the door. Am J Cancer Res 2012;2(x):xx-xx.
Elizabeth Hopper-Borge, et al: Are ABC transporters relevant to breast cancer? Am J Cancer Res 2012;2(x):xx-xx.
Yun Yen, et al: Salivary gland and clinical management. Am J Cancer Res 2012;2(x):xx-xx.
Li Jiao, et al: Dietary intake and tumor microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Courtney W. Houchen, et al: Comparative evaluation of novel putative stem cell markers and tumor suppressor microRNAs in Barrett’s
esophagus. Am J Cancer Res 2012;2(x):xx-xx.
Bernard S. Lopez, et al: DNA double strand break repair in mammalian cells: competition canonical NHEJ versus Alternative NHEJ;
consequence on genome stability-instability and on radiation therapy strategies. Am J Cancer Res 2012;2(x):xx-xx.
José Courty, et al: Glycoaminoglycans modulate antitumor activity of peudopeptides that target nucleoproteins. Am J Cancer Res 2012;2(x):xx-xx.
Federica Moschella, et al: Immunomodulatory properties of anticancer drugs for improving the efficacy of cancer immunotherapy. Am J Cancer
Res 2012;2(x):xx-xx.
Rosa Marina Melillo, et al: Cancer-related inflammation in thyroid caner. Am J Cancer Res 2012;2(x):xx-xx.
Vijayalakshmi (Viji) Shridhar, et al: Role of endosulfatases HSulf-1 and -2 in women's cancer. Am J Cancer Res 2012;2(x):xx-xx.
Catherine Muller, et al: Stromal Adipocytes : a new component of the tumour microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Cai Weibo, et al: 64Cu-Labeled AApeptides: A new class of PET tracers for cancer imaging. Am J Cancer Res 2012;2(x):xx-xx.
Eran Andrechek, et al: Integrative genomics and breast cancer, a review. Am J Cancer Res 2012;2(x):xx-xx.
Dan Mercola, et al: Should we treat the “stroma” of Prostate Cancer? Am J Cancer Res 2012;2(x):xx-xx.
Calvin P.H. Vary, et al: Proteomic analysis of endoglin-deficient TRAMP prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Bingbing Dai, et al: Molecular mechanism of MEK inhibitor resistance. Am J Cancer Res 2012;2(x):xx-xx.
Jennifer Isaacs, et al: E-cadherin suppression initiates profound genetic and developmental signaling events in prostate cancer. Am J Cancer
Res 2012;2(x):xx-xx.
Leland W. K. Chung, et al: Cell signaling network linking cancer growth and metastasis to the skeleton. Am J Cancer Res 2012;2(x):xx-xx.
Richard Kremer, et al: Parathyroid hormone related protein(PTHrP): biology and targeting strategies. Am J Cancer Res 2012;2(x):xx-xx.
Claudia Lanari, et al: Fibroblast growth factor receptors in breast cancer. A stromal-epithelial connection. Am J Cancer Res 2012;2(x):xx-xx.
Rosana Risques, et al: Senescence-associated markers can distinguish ulcerative colitis patients at risk for cancer progression. Am J Cancer
Res 2012;2(x):xx-xx.
Robert W. Sobol, Jr., et al: Expression profile modulation in DNA Polymerase ß null mouse embryonic fibroblasts. Am J Cancer Res 2012;2(x):xx-
xx.
Shahriar Koochekpour, et al: Prostate cancer biomarkers. Am J Cancer Res 2012;2(x):xx-xx.
Panagiotis A. Konstantinopoulos, et al: The role of oxidative stress in ovarian cancer pathogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Ahmed A Ahmed, et al: Aiming at a moving target: targeting mitosis in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Steven A Johnsen, et al: Cell cycle-dependent regulation of histone mRNA 3’ end processing. Am J Cancer Res 2012;2(x):xx-xx.
Jianxun Song, et al: Development of tumor antigen-specific T lymphocytes from stem cells. Am J Cancer Res 2012;2(x):xx-xx.
Euan Stronach, et al: The DNA damage response to platinum chemotherapy in ovarian cancer. Am J Cancer Res 2012;2(x):xx-xx.
Shiaw-Yih Lin, et al: Replication stress response defects in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hani Gabra, et al: The role of OPCML and the IgLON family in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Henning Willers, et al: Preclinical modeling of personalized radiation oncology: obstacles and opportunities. Am J Cancer Res 2012;2(x):xx-xx.
Massimo Broggini, et al: K-RAS as a determinant of response to chemotherapy. Am J Cancer Res 2012;2(x):xx-xx.
Anja van de Stolpe, et al: The future of cancer pathology diagnostics – with a focus on CTC-based diagnostics. Am J Cancer Res 2012;2(x):xx-xx.
Joao Taborda Barata, et al: Beyond expression: regulation of PTEN tumor suppressor activity by posttranslational mechanisms that do not
negatively affect PTEN levels. Am J Cancer Res 2012;2(x):xx-xx.
Lu Q. Le, et al: Neurofibromas: cells of origin and the tumor microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Wafik S. El-Deiry, et al: Novel assay development for biomarker detection on isolated circulating tumor cells. Am J Cancer Res 2012;2(x):xx-xx.
Chun Li, et al: Targeted delivery of nanoparticles targeted to EphB4 receptors. Am J Cancer Res 2012;2(x):xx-xx.
Chris McCabe, et al: Enhancing the sodium iodide symporter in thyroid cancer. Am J Cancer Res 2012;2(x):xx-xx.
Qianben Wang, et al: Role of pioneer transcription factors in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Vasiliki Bravou, et al: Novel insights in colorectal cancer molecular pathogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Seok-Geun Lee, et al: AEG-1 in tumorigenesis of the central nervous system. Am J Cancer Res 2012;2(x):xx-xx.
Suyun Huang, et al: Role of FoxM1 transcription factor in glioblastoma formation and progression. Am J Cancer Res 2012;2(x):xx-xx.
Silvia Deaglio, et al: The tumor microenvironment in chronic lymphocytic leukemia: clues for identifying novel therapeutic targets. Am J Cancer
Res 2012;2(x):xx-xx.
Huafeng Zhang, et al: The role of hypoxia and HIF1 in cancer metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Brandon L Pierce, et al: Unidentified genetic variants influence pancreatic cancer risk: An analysis of the PanScan genome-wide association
study. Am J Cancer Res 2012;2(x):xx-xx.
Tao Zhu, et al: New insight of growth hormone and prolactin in cancer development. Review. Am J Cancer Res 2012;2(x):xx-xx.
Tao Zhu, et al: Gene amplification of growth hormone predict a worse survival outcome in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Rotem Karni, et al: The role of SR proteins in cancer development and progression. Am J Cancer Res 2012;2(x):xx-xx.
Peng Lee, et al: Androgen receptor and cofactors in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Tokuhiro Chano, et al: RB1CC1 interferes in the crosstalk between autophagy and senescence. Am J Cancer Res 2012;2(x):xx-xx.
Ji-Liang Li, et al: Role of Notch signaling in tumor resistance to anti-cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Alberto Izzotti, et al: MicroRNA in lung cancer prevention. Am J Cancer Res 2012;2(x):xx-xx.
Wancai Yang, et al: Molecular mechanisms of dietary factors in colorectal cancer prevention. Am J Cancer Res 2012;2(x):xx-xx.
Frederic Bost, et al: Metformin and Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Santiago Ramón y Cajal Agüeras, et al: Overcoming cellular stress in malignant cells. The role of peIF4E. Am J Cancer Res 2012;2(x):xx-xx.
Alberto Izzotti, et al: MicroRNA in lung cancer prevention. Am J Cancer Res 2012;2(x):xx-xx.
Daolin Tang, et al: Role of autophagy in pancreatic cancer. Am J Cancer Res 2012;2(x):xx-xx.
Katherine A Vallis, et al: The development of radioimmunoconjugates directed against intra-nuclear targets. Am J Cancer Res 2012;2(x):xx-xx.
Lucia Languino, et al: Integrin signaling in cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Tao Ye, et al: Histone deacetylase inhibitor, largazole, inhibits hepatocellular carcinoma growth both in vitro and in mouse model system. Am J
Cancer Res 2012;2(x):xx-xx.
Andrei Thomas-Tikhonenko, et al: Smad4 inactivation in colon cancer cooperates with deregulation of the Myc oncoprotein to promote tumor
angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Xiang-Yang (Shawn) Wang, et al: CD204 represses toll-like receptor agonist elicited antigen-specific antitumor immune response. Am J Cancer
Res 2012;2(x):xx-xx.
Masahisa Jinushi, et al: The regulatory mechanisms of cancer stem cell activities by immunological niche. Am J Cancer Res 2012;2(x):xx-xx.
Jeff Holst, et al: Amino acid transport in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Santosh Kesari, et al: Review of leptomeningeal metastasis in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
(PDFs in this page may have not been proofed yet)
Volume 2, Issue 2;2012
Xuguang Zhu, Sheue-yann Cheng: Modeling follicular thyroid cancer for future therapies. Am J Cancer Res 2012;2(2):130-140. (Abstract,
0000100, full text PDF).
Eiji Takaoka, Hiroshi Sonobe, Kunihiro Akimaru, Shuji Sakamoto, Taro Shuin, Masanori Daibata, Takahiro Taguchi, Akira Tominaga: Multiple
sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell
line. Am J Cancer Res 2012;2(2):141-152. (Abstract, 0000107, full text PDF).
Yuri Sheikine, Elizabeth Genega, Jonathan Melamed, Peng Lee, Victor E. Reuter, Huihui Ye: Molecular genetics of testicular germ cell tumors.
Am J Cancer Res 2012;2(2):153-167.(Abstract, 0000104, full text PDF).
Christina Pettan-Brewer, John Morton, Sarah Cullen , Linda Enns, Keffy R.M. Kehrli, Julia Sidorova, Jorming Goh, Rebecca Coil, Warren C.
Ladiges: Tumor growth is suppressed in mice expressing a truncated XRCC1 rotein. Am J Cancer Res 2012;2(2):168-177. (Abstract, 0000101,
full text PDF).
Ali R Jazirehi, Peter B Wenn, Mohsen Damavand: Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in
melanoma therapy. Am J Cancer Res 2012;2(2):178-191. (Abstract, 0000096, full text PDF).
Manawapat A, Stubenrauch F, Russ R, Munk C, Kjær SK, Iftner T: Physical state and viral load as predictive biomarkers for persistence and
progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study. Am J Cancer Res 2012;2(2):
192-203. (Abstract, 0000095, full text PDF).
Charles F. Babbs: Predicting success or failure of immunotherapy for cancer: insights from a clinically applicable mathematical model. Am J
Cancer Res 2012;2(2):204-213. (Abstract, 0000097, full text PDF).
Rebecca T. Marquez, Liang Xu: Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res
2012;2(2):214-221. (Abstract, 0000098, full text PDF).
Najmunnisa Nasreen, Nazli Khodayari, Kamal A: Mohammed: Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel
approach. Am J Cancer Res 2012;2(2):222-234. (Abstract, 0000102, full text PDF).
Danilo Swann Matassa, Maria Rosaria Amoroso, Francesca Maddalena, Matteo Landriscina, Franca Esposito: New insights into TRAP1
pathway. Am J Cancer Res 2012;2(2):235-248. (Abstract, 0000108, full text PDF).
Ichiro Yajima, Mayuko Y Kumasaka, Yuji Naito, Toshikazu Yoshikawa, Hiro Takahashi, Yoko Funasaka, Tamio Suzuki, Masashi Kato: Reduced
GNG2 expression levels in mouse and human malignant melanomas. Am J Cancer Res 2012;2(x):xx-xx.(Abstract, 0000105, full text PDF).
Amy C. Sievers, Joseph H. Antin: Post-transplant lymphoproliferative disorders, a review. Am J Cancer Res 2012;2(x):xx-xx.
Tanya Kalin, et al: Signaling pathways regulated by FoxM1 oncogene in lung cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ann Richmond, et al: Interrelationship between aurora kinaseA and inhibitor of kappa-beta kinase (IKK) inhibition in melanoma. Am J Cancer
Res 2012;2(x):xx-xx.
Stephen A. Boppart, et al: Ultrastructural changes during tumor development detected by polarization-sensitivie optical coherence tomography.
Am J Cancer Res 2012;2(x):xx-xx.
Franca Esposito, et al: New insights into the TRAP1 pathway. Am J Cancer Res 2012;2(x):xx-xx.
Jenny Wang, et al: TGFb-mediated suppression of metastasis in colon cancer. Am J Cancer Res 2012;2(x):xx-xx.
Dan A. Liebermann, et al: Gadd45 family of genes sensors of i oncogenic stress. Am J Cancer Res 2012;2(x):xx-xx.
Bharat B. Aggarwal, et al: Inflammation and cancer: a story of association and dissociation. Am J Cancer Res 2012;2(x):xx-xx.
Michael A. Tainsky, et al: Innate immunity in cancer development. Am J Cancer Res 2012;2(x):xx-xx.
Elizabeth Moran, et al: Molecular role of the retinoblastoma family in suppression of osteosarcoma, and in control of normal osteoblast
differentiation. Am J Cancer Res 2012;2(x):xx-xx.
Jong-Wan Park, et al: Does HIF promote or demote skin cancer? Am J Cancer Res 2012;2(x):xx-xx.
Asit K. De, et al: Role of heat shock protein 27 in human cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hyeong-Reh Choi Kim, et al: A novel mechanism of PDGF signaling in human cancer. Am J Cancer Res 2012;2(x):xx-xx.
Elizabeth M. Wilson, et al: Androgen receptor action in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
François E. Paris, et al: Ionizing radiation induces acute and long terms responses in endothelial cells. Am J Cancer Res 2012;2(x):xx-xx.
Dmitry Pshezhetskiy, et al: Bacterial infection mediates prostate cancer progression through activation of sphingosine kinase 1. Am J Cancer
Res 2012;2(x):xx-xx.
Xiang-ping Li, et al: Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Am J Cancer Res
2012;2(x):xx-xx.
Franceca Ricci, Massimo Broggini, Giovanna Damia: Tumor initianting cell of ovarian cancer. Am J Cancer Res 2012;2(x):xx-xx.
Chiun Hsu, et al: "off-target" effects of sorafenib for the treatment of hepatocellular carcinoma: translational and clinical implications. Am J Cancer
Res 2012;2(x):xx-xx.
Gopal C. Kundu, et al: Osteopontin, a potentially important therapeutic target in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Stephen H. Thorne, et al: Combining biological therapies for optimal treatment of cancer. Am J Cancer Res 2012;2(x):xx-xx.
Patrick Pollard, et al: Metabolic biomarkers: a new era in cancer identification and stratification. Am J Cancer Res 2012;2(x):xx-xx.
Olivier Cuvillier, et al: Sphingosine 1-phosphate, a cancer therapeutic target. Am J Cancer Res 2012;2(x):xx-xx.
Stephanie Ma, et al: microRNA regulation in cancer stem cells. Am J Cancer Res 2012;2(x):xx-xx.
Dina Allam, Leo K. Iwai, Paul H. Huang: Discoidin domain receptor signalling networks in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Mong-Hong Lee, et al: Role of 14.33 sigma in DNA damage response. Am J Cancer Res 2012;2(x):xx-xx.
Qiuyin Cai, et al: Mitochondrial DNA variations with breast cancer risk and outcome. Am J Cancer Res 2012;2(x):xx-xx.
Jacques E. Nor, et al: Stem cells in salivary gland cancer. Am J Cancer Res 2012;2(x):xx-xx.
James A. Koziol, Zhenyu Jia, Michael B. Lilly, Dan A. Mercola: The use of nomogram predictions as comparators for adjuvant treatment studies
in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Durga Udayakumar, Hensin Tsao: Role of Eph Receptors in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Fahd Al-Mulla, et al: RKIP interacts with KEAP1 to promote chemotherapeutic resistance. Am J Cancer Res 2012;2(x):xx-xx.
Yangbing Zhao, et al: Influence of T cell stimulation on anti-tumor activities of RNA electroporated T cells. Am J Cancer Res 2012;2(x):xx-xx.
Fahd Al-Mulla, et al: Chromothripsis in colorectal cancer. Am J Cancer Res 2012;2(x):xx-xx.
Mei-Yi Lee, Cheng-Yang Chou, Meng-Ru Shen: Epithelial-mesenchymal transition in cervical cancer. Am J Cancer Res 2012;2(x):xx-xx.
Zanella F, García B, Callejas S, Peregrina S, Carnero A, Wolfgang Link: Chemical genetic rescue profiling for target deconvolution. Am J Cancer
Res 2012;2(x):xx-xx.
Zhenyu Jia, Yipeng Wang, Kai Ye, Xiao-Qin Xia, Yuanjie Hu, Hui Li, Sha Tang, Waldemar Lernhardt, James A. Koziol, Michael McClelland, Dan
Mercola: Increasing sample size does not boost power if confounding factors are not controlled – a study of prostate cancer expression profiles.
Am J Cancer Res 2012;2(x):xx-xx.
Daniel Monleon, et al: Cancer metabolism beyond the Warburg effect. Am J Cancer Res 2012;2(x):xx-xx.
Guido Kroemer: Autophagic cell death in cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Claudio Sorio, et al: Applications of Fourier transformed microspectroscopy in cancer research. Am J Cancer Res 2012;2(x):xx-xx.
Samir Iqbal, et al: Nanotechnology for cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hinrich Gronemeyer: Epigenetic regulation of cancer-selective TRAIL-mediated apoptosis. Am J Cancer Res 2012;2(x):xx-xx.
Margaret A. Knowles: Preclinical models for bladder cancer. Am J Cancer Res 2012;2(x):xx-xx.
Subbaya Subramanian, et al: MicroRNA gene regulatory newtorks in sarcomas. Am J Cancer Res 2012;2(x):xx-xx.
Maurizio D’Incalci, et al: Mechanism of action of marine natural products with antitumor properties. Am J Cancer Res 2012;2(x):xx-xx.
Lucio Miele, et al: Notch signaling in breast cancer: context dependence and therapeutic targeting. Am J Cancer Res 2012;2(x):xx-xx.
Max Costa, et al: Histone tail modifications and Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ali Jazirehi, et al: Bortezomib for the treatment of melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Donald J. Johann, et al: Advancing molecular profiling with mass spectrometry based clinical proteomics. Am J Cancer Res 2012;2(x):xx-xx.
Michael L. Freeman, et al: Repression of Nrf2 signaling. Am J Cancer Res 2012;2(x):xx-xx.
Michael J. Seckl, et al: Targeting the JAK/STAT signalling pathway in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Andrew E. Aplin, et al: FOXD3 regulation of migration in melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Thomas Helleday: The synthetic lethal concept for novel cancer treatments: potentials and pitfalls. Am J Cancer Res 2012;2(x):xx-xx.
Vincent L. Cryns: Molecular chaperones and cancer. Am J Cancer Res 2012;2(x):xx-xx.
Francois X. Claret, et al: Evolving Strategies for treatment of HER2-positive breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Alfredo Fusco, et al: RNA and microRNA expression profile in pituitary adenomas. Am J Cancer Res 2012;2(x):xx-xx.
Su Hao Lo, et al: The dual roles of cten in tumorigenesis. Am J Cancer Res 2012;2(x):xx-xx.
Ben Ho Park: Androgen receptor as a targeted therapy for breast cancer (mini-review). Am J Cancer Res 2012;2(x):xx-xx.
Philip Hahnfeldt, et al: Intercellular interactions as a modulator of carcinogenesis and cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Markus H. Frank, et al: Role of ABCB5 in cancer multidrug resistance. Am J Cancer Res 2012;2(x):xx-xx.
Tohru Kiyono, et al: An in vitro multistep carcinogenesis model for both HPV- positive and -negative human oral squamous cell carcinoma. Am J
Cancer Res 2012;2(x):xx-xx.
Ratna K. Vadlamudi, et al: MicroRNA signaling in breast cancer: novel therapeutics. Am J Cancer Res 2012;2(x):xx-xx.
David M. Owens, et al: Dissecting the role of CD200 signaling in tumor progression and metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Balakrishna L. Lokeshwar, et al: Spicing up anticancer medicine: time to seriously consider dietary anticancer compounds in cancer therapy. Am
J Cancer Res 2012;2(x):xx-xx.
Shanaz H. Dairkee, et al: Novel cancer models to assist in oncogenic pathway identification. Am J Cancer Res 2012;2(x):xx-xx.
Gutian Xiao, et al: Negative regulation of NF-kappaB in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Paul Szabolcs, et al: Challenges and opportunities: immune reconstitution after cord blood transplantation. Am J Cancer Res 2012;2(x):xx-xx.
Zdenko Herceg, et al: Epigenetic mechanisms, stem cells and cancer (review). Am J Cancer Res 2012;2(x):xx-xx.
Venuprasad K. Poojary, et al: TGF-beta and regulation of anti-tumor immune response. Am J Cancer Res 2012;2(x):xx-xx.
Shi-Yong Sun, et al: Impact of genetic alterations on mTOR-targeted cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Othon Iliopoulos, et al: HIF2a as a therapeutic target for cancer angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Hari K Koul, et al: Tetrandrine targets cell cycle to inhibit prostate cancer growth. Am J Cancer Res 2012;2(x):xx-xx.
Godefridus J. Peters, et al: Translation of animal models to the patient; why do they not always work? Am J Cancer Res 2012;2(x):xx-xx.
Ester Hammond, et al: DNA damage signalling in hypoxia. Am J Cancer Res 2012;2(x):xx-xx.
Jiaoti Huang, et al: Cell origin for prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Shuichi Kaneko, et al: Stem cells of hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Bo Huang, et al: Mast cells: toward the road of remodeling tumor microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Haval Shirwan: Cancer vaccines, an update. Am J Cancer Res 2012;2(x):xx-xx.
Masamitsu Yamaguchi, et al: Regulation of Hippo pathway genes by DRE/DREF system. Am J Cancer Res 2012;2(x):xx-xx.
Karim Nayernia, et al: PhD,Cancer stem cells: a new approaches for diagnostics and therapy. Am J Cancer Res 2012;2(x):xx-xx.
Matthew L. Anderson: MicroRNAs in gynecologic cancer. Am J Cancer Res 2012;2(x):xx-xx.
M.R. Satyanarayana Rao, et al: Molecular and Cellular heterogeneity of Glioma. Am J Cancer Res 2012;2(x):xx-xx.
Qian Zheng, et al: Can chemotherapy be individualized in prostate cancer? Am J Cancer Res 2012;2(x):xx-xx.
Pablo Menendez, et al: Modelling sarcomas using MSCs. Am J Cancer Res 2012;2(x):xx-xx.
Kosaku Iwatsubo, et al: Epac1 as a mediator of melanoma metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Sam Thiagalingam, et al: Epigenetic regulation of breast cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Christopher H. Parsons, et al: SHV interactions with the cell surface: new paradigms for HIV-associated cancer pathogenesis and the
development of novel therapeutic approaches. Am J Cancer Res 2012;2(x):xx-xx.
Yuval Shaked, et al: The role of bone marrow derived cells in tumor angiogenesis and growth. Am J Cancer Res 2012;2(x):xx-xx.
Irina Nazarenko, et al: Different modes of intercellular communication and their impact on tumour progression. Am J Cancer Res 2012;2(x):xx-xx.
Anjali Jain, et al: Targeting mTOR in PTEN-null NSCLC after acquired resistance to EGFR-TKIs. Am J Cancer Res 2012;2(x):xx-xx.
François Ghiringhelli: Targeting myeloid derived suppressor cells to relieve tumor induce immunosuppression. Am J Cancer Res 2012;2(x):xx-xx.
Mark W Jackson, et al: Defining novel tumor suppressor-oncogene interactions in mammary cell transformation. Am J Cancer Res 2012;2(x):xx-
xx.
Wenxing Zheng, et al: Secretory cells of fallopian tube as the main source for female pelvic serous carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Sandra Orsulic, et al: Expression of HOXB13 in adult human tissues and its relevance to cancer. Am J Cancer Res 2012;2(x):xx-xx.
Jeanette H.W. Leusen, et al: Mechanisms of antibody therapy for cancer. Am J Cancer Res 2012;2(x):xx-xx.
Stephen Safe, et al: The effects of some anticancer drugs on growth inhibition and Sp transcription factor downregulation in cancer. Am J Cancer
Res 2012;2(x):xx-xx.
Prahlad T. Ram, et al: Signaling and mutations in RTK and GPCR networks in melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Qi Dai, et al: Major contributors to isoprotane metabolite, an accurate biomarker for oxidative stress. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Marc A. Lobaccaro, et al: Cholesterol, prostate cancer and LXR: the good, the bad and the ugly. Am J Cancer Res 2012;2(x):xx-xx.
Eitan Shaulian, et al: New mechanisms and target mediating AP-1 activity in transformation. Am J Cancer Res 2012;2(x):xx-xx.
Guojun Wu, et al: EMT and metastatic breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Franco Capozza, et al: Caveolae/Caveolins in skin cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Devanand Sarkar, et al: The transcription factor LSF: a novel oncogene for hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Bin Zhang, et al: Overcoming CD39/CD73-mediated cancer immune evasion. Am J Cancer Res 2012;2(x):xx-xx.
Sandro De Falco, et al: Over-expression of a PlGF2 variant in tumor cells inhibits VEGF-dependent tumor angiogenesis. Am J Cancer Res 2012;2
(x):xx-xx.
Taro Yamashita, et al: Molecular pathogenesis of hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Bin Guo, et al: Regulation of histone methylation by cancer chemopreventive agents. Am J Cancer Res 2012;2(x):xx-xx.
Michael Ohh, et al: Molecular pathobiology of von Hippel-Lindau disease. Am J Cancer Res 2012;2(x):xx-xx.
Sean Bong Lee, et al: Wnt Signaling Pathway and Wilms Tumor. Am J Cancer Res 2012;2(x):xx-xx.
R. Daniel Bonfil, et al: Mechanisms of prostate cancer bone metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Fei Chen, et al: Does apoptosis facilitate carcinogenesis? Am J Cancer Res 2012;2(x):xx-xx.
G. Steven Bova, et al: Why integrated clinical-molecular autopsy studies are critical to future advances in personalized medicine. Am J Cancer
Res 2012;2(x):xx-xx.
Tom Luedde, et al: Inflammatory signaling pathways in hepatocarcinogenesis: From Mouse models to new therapeutic strategies? Am J Cancer
Res 2012;2(x):xx-xx.
Arnold Chin, et al: Toll-like Receptors in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ignacio Perez-Roger, et al: proteasome inhibitors in leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Ceshi Chen, et al: The Hippo tumor suppressor pathway and breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Martin Dutertre, et al: The emerging role of RNA-binding proteins in oncogenesis and stress responses. Am J Cancer Res 2012;2(x):xx-xx.
Kyu-Won Kim, et al: Roles of ARD1 variants in tumor-angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Olivier Gires, et al: Cancer stem cell markers and their respective functions. Am J Cancer Res 2012;2(x):xx-xx.
Fahri Saatcioglu, et al: Regulation of apoptosis in prostate cancer cells by androgens (review). Am J Cancer Res 2012;2(x):xx-xx.
Cristiano Ferlini, et al: Cytoskeletal driven mechanisms of drug resistance in solid tumors. Am J Cancer Res 2012;2(x):xx-xx.
Ramana Davuluri, et al: Alternative promoter genes in development and cancer. Am J Cancer Res 2012;2(x):xx-xx.
Yin-Yuan Mo, et al: Role of tumor suppressive microRNAs in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Ajay Goel, et al: Cancer chemoprevention by dietary agents. Am J Cancer Res 2011;1(1):xx-xx. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Ehrland Ricci, et al: Metabolic control of cell deaths. Am J Cancer Res 2012;2(x):xx-xx.
Kiyoshi Ariizumi, et al: The role of co-inhibitory receptors in suppression of anti-tumor T cells by melanoma. Am J Cancer Res 2012;2(x):xx-xx.
Jianhua Luo, et al: Integrin and malignancies. Am J Cancer Res 2012;2(x):xx-xx.
Jörg Wischhusen, et al: Immunological characteristics of cancer stem cells - what do we know? Am J Cancer Res 2012;2(x):xx-xx..
Yoh Takuwa, et al: Role of the lysophospholipid mediator sphingosine-1-phosphate in tumor angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Yaacov Ben-David, et al: The role of transcription factor Fli-1 in development and malignant transformation. Am J Cancer Res 2012;2(x):xx-xx.
Rozita Bagheri-Yarmand, et al: The transcription factor ATF4: a novel tumor suppressor gene in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Yun Wu, et al: Neuroendocrine carcinomas of the breast are resistant to neoadjuvant chemotherapy. Am J Cancer Res 2012;2(x):xx-xx.
Stéphan Vagner, et al: mRNA 3' end heterogeneity in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Jae-Hong Kim, et al: BLT2, a low-affinity receptor for leukotriene B4, is associated with paclitaxel resistance in breast MCF7/ADR cells. Am J
Cancer Res 2012;2(x):xx-xx.
Yong-Jie Lu, et al: Chromosome rearrangement associated inactivation of tumor suppressor genes in prostate cancer. Am J Cancer Res 2012;2
(x):xx-xx.
Keshav Singh, et al: InterGenomic cross talk and its role in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Gareth Inman, et al: Targeting BMP signaling for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Gareth Inman, et al: Smad activation in Ovarian Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Wei Du, et al: Rb, E2F proteins and cellular stress. Am J Cancer Res 2012;2(x):xx-xx.
Shazib Pervaiz, et al: Redox regulation of cell fate in cancer cells. Am J Cancer Res 2012;2(x):xx-xx.
Zhihua Liu, et al: S100 protein family and cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hongchuan Jin, et al: Epigenetic silencing of KL in gastric cancer. Am J Cancer Res 2012;2(x):xx-xx.
Eldad Zacksenhaus, et al: Cancer stem cells at single cell resolution. Am J Cancer Res 2012;2(x):xx-xx.
Mathias Chamaillard, et al: Licensing intestinal homeostasis and tumorigenesis by the inflammasome. Am J Cancer Res 2012;2(x):xx-xx.
Federica Cavallo, et al: Oncoantigens for the immunological prevention of cancer. Am J Cancer Res 2012;2(x):xx-xx.
Roberto Chiarle, et al: Anaplastic Lymphoma Kinase and oncogenic signals in tumors. Am J Cancer Res 2012;2(x):xx-xx.
Xin-yuan Guan, et al: Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in
hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Mohamed El-Tanani, et al: Genetic regulation of human breast cancer metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Gudrun Koehl, et al: Can mTOR inhibition prevent tumor progression or is it only slowing tumor growth? Am J Cancer Res 2012;2(x):xx-xx.
Torben F. Orntoft, et al: Molecular biomarkers for bladder cancer, the use of combined parameters for disease course prediction. Am J Cancer
Res 2012;2(x):xx-xx.
Roberto Diaz, et al: Radiation-Induced Neoantigens: Imaging and Therapeutic Implications. Am J Cancer Res 2012;2(x):xx-xx.
A. Postigo, et al: ZEB proteins as key regulators of cancer stem cells and tumor invasiveness and metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Chenguang Wang, et al: Cyclin D1 regulation of gene transcription. Am J Cancer Res 2012;2(x):xx-xx.
Preet M. Chaudhary, et al: KSHV vFLIP induced genes is primary effusion lymphoma. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Baptiste Vincourt, et al: Consequences of Outside-In Signaling: a matter of ECM integrity. Am J Cancer Res 2012;2(x):xx-xx.
Yong Liao, et al: Oncogenic phophatase Wip1 as a therapeutic target for chemosensitization in human breast cancer. Am J Cancer Res 2012;2(x):
xx-xx.
Yong Liao, et al: Nuclear reprogramming and oncogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Jean-Baptiste Vincourt, et al: TGF-receptor independent modulation of Smad signaling by procollagen propeptides. Am J Cancer Res 2012;2(x):
xx-xx.
Grigory Dianov, et al: Targeting base excision repair for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Lucia Altucci, et al: The Epigenome of cancer: a new era for targets and therapy. Am J Cancer Res 2012;2(x):xx-xx.
Christophe Cazaux, et al: Misregulation of genes involved in DNA repair and DNA damage checkpoint confers a poor prognosis in breast cancer
patients. Am J Cancer Res 2012;2(x):xx-xx.
Namhoon Cho, et al: miRNA regulation to affect hormonal refractory prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Giovanni Melillo, et al: Targeting the hypoxic tumor microenvironment for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Thomas Reinheckel, et al: Cysteine cathepsins as targets for cancer therapy: lessons from mouse models. Am J Cancer Res 2012;2(x):xx-xx.
Simone Fulda, et al: Targeting apoptosis signaling for cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
David “Neil” Hayes, et al: The Genomics of Lung Cancer and its role in clinical practice, biomarkers, and model systems. Am J Cancer Res 2012;
2(x):xx-xx.
Peter Shaw, et al: Dynamic and interactive properties of ETS transcription factors linked to tumor development. Am J Cancer Res 2012;2(x):xx-xx.
Habib Boukerche, et al: MDA-9/syntenin, angiogenesis and tumor progression. Am J Cancer Res 2012;2(x):xx-xx.
Shigeomi Shimizu, et al: Molecular mechanisms of alternative autophagy. Am J Cancer Res 2012;2(x):xx-xx.
Thomas Iftner, et al: Physical state and viral load as predictive biomarkers for persistence and progression of high risk HPV-infected cervical
lesions: data from a population based prospective cohort follow up of 8656 women for 12 years. Am J Cancer Res 2012;2(x):xx-xx.
Nicholas A Saunders, et al: molecular targeted therapies and traditional chemotherapeutics: what will be best for patients. Am J Cancer Res
2012;2(x):xx-xx.
Stephen T.C. Wong, et al: New systems biology approach for cancer drug repositioning and combination. Am J Cancer Res 2012;2(x):xx-xx.
Ahmed Ashour Ahmed, et al: Aiming at a moving target: targeting mitosis in canccer. Am J Cancer Res 2012;2(x):xx-xx.
Eva M. Harth, et al: Tumor regression of non-small lung cancer with targeted nanosponge delivery system. Am J Cancer Res 2012;2(x):xx-xx.
Sebastien Jauliac, et al: NFAT and cancer: the Ying and the Yang. Am J Cancer Res 2012;2(x):xx-xx.
Jose L. Yelamos, et al: PARP proteins: New players in tumours development. Am J Cancer Res 2012;2(x):xx-xx.
Dosik Min, et al: Regulation of Phospholipase D expression in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Aart Jochemsen, et al: The regulation and functions of MDMX. Am J Cancer Res 2012;2(x):xx-xx.
Michael Hsiao, et al: Platform development for high-throughput identifications and validations of novel tumor-associate genes. Am J Cancer Res
2012;2(x):xx-xx.
Albert S Mellick, et al: Small RNAs and bone marrow mediated tumour vascularisation. Am J Cancer Res 2012;2(x):xx-xx.
Albert S Mellick, et al: Endothelial progenitor cells and clinical course and late stage cancer. Am J Cancer Res 2012;2(x):xx-xx.
Gary W. Reuther, et al: Recent advances in JAK2 function in myeloproliferative neoplasms. Am J Cancer Res 2012;2(x):xx-xx.
Pierre Laurent-Puig, et al: EGFR mutated lung cancers a specific disease? Am J Cancer Res 2012;2(x):xx-xx.
Serge Roche, et al: Src family tyrosine kinase signalling in advanced colon carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
Horng-Mo Lee, et al: Nodal is a key molecular switch in regulating aerobic glycolysis in human glioma cells. Am J Cancer Res 2012;2(x):xx-xx.
Nelson Dusetti, et al: TP53INP1 a tumor suppressor gene early disrupted in digestive tract cancerogenesis. Am J Cancer Res 2012;2(x):xx-xx.
David J. MacEwan, et al: MicroRNAs as a new therapeutic target for leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Peter Igaz, et al: Novel aspects of adrenocortical and adrenomedullary tumorigenesis. Am J Cancer Res 2012;2(x):xx-xx.
David Bates, et al: Mechanisms of lymphatic metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Raymond L. Stallings, et al: The role of microRNAs in pediatric cancers. Am J Cancer Res 2012;2(x):xx-xx.
Francoise Redini, et al: How can the micro-environment influence primary bone tumor progression. Am J Cancer Res 2012;2(x):xx-xx.
Andreas G. Bader, et al: Development of microRNA therapeutics. Am J Cancer Res 2012;2(x):xx-xx.
Carlo Gambacorti-Passerini, et al: The development of imatinib for Chronic Myeloid Leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Chang-Deng Hu, et al., ATF2: subcellular localization and oncogenic activity. Am J Cancer Res 2012;2(x):xx-xx.
Fuyu Tamanoi: Mesoporous silica nanoparticles as a delivery system for anticancer drugs and siRNA. Am J Cancer Res 2012;2(x):xx-xx.
Maria Kavallaris, et al: Aurora Kinase Inhibitors in Cancer Therapy. Am J Cancer Res 2012;2(x):xx-xx.
Victoria Cowling, et al: The role of the 7-methylguanosine cap in tumours. Am J Cancer Res 2012;2(x):xx-xx.
Valeria Poli, et al: Stat3 and cancer: dangerous liaisons at multiple levels. Am J Cancer Res 2012;2(x):xx-xx.
Lisa D. Belmont, et al: Pre-clinical models identify predictive biomarkers for the combination of a Bcl-2/Bcl-xL inhibitor and paclitaxel in ovarian
cancer. Am J Cancer Res 2012;2(x):xx-xx.
Weinong Han, Mei Ming, and Yu-Ying He: Sensitization of apoptosis of keratinocytes in response to ultraviolet damage. Am J Cancer Res 2012;2
(x):xx-xx.
Najmunnisa Nasreen, Nazli Khodayari, Kamal A. Mohammed: Advances in malignant mesothelioma therapy: targeting EphA2 - a novel approach.
Am J Cancer Res 2012;2(x):xx-xx.
Ralph Wasch, et al: Cell cycle regulation in acute leukemia. Am J Cancer Res 2012;2(x):xx-xx.
Alain Piche, et al: Death receptors and ovarian cancer: The TRAILs of resistance. Am J Cancer Res 2012;2(x):xx-xx.
John A. Copland, et al: Novel molecular targets for therapy in renal cell carcinoma. Am J Cancer Res 2012;2(x):xx-xx.
John A. Copland, et al: Foxo3a as a novel target for therapy. Am J Cancer Res 2012;2(x):xx-xx.
Nathalie Andrieu-Abadie, et al: Ceramide and Bcl-2 family members in cancer cell signaling. Am J Cancer Res 2012;2(x):xx-xx.
Jeniffer Y. Zhang, et al: Differential roles of JNK or (AP1 proteins) in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Claudio Brancolini, et al: Class IIA HDAC in the control of cell proliferation. Am J Cancer Res 2012;2(x):xx-xx.
Brigitte N. Gomperts, et al: Stem cells in lung cancer. Am J Cancer Res 2012;2(x):xx-xx.
Kairbaan Hodivala-Dilke: Tumour angiogenesis and new insights. Am J Cancer Res 2012;2(x):xx-xx.
Lesley Stark, et al: Nucleolar translocation of NF-kappaB/RelA in the anti-cancer effects of non-steroidal anti-inflammatory drugs. Am J Cancer
Res 2012;2(x):xx-xx.
Annie Huang, et al: Myc - a recurrent problem in medulloblastoma. Am J Cancer Res 2012;2(x):xx-xx.
Irina Nazarenko, et al: A comparative analysis of the binding capacity of tumour-derived exosomes to their target cells: impact of receptor-ligand
interactions. Am J Cancer Res 2012;2(x):xx-xx.
Kirsten Ness, et al: Disability and social isolation in adult survivors of childhood brain tumors. Am J Cancer Res 2012;2(x):xx-xx.
Kirsten Ness, et al: Musculoskeletal late effects in childhood cancer survivors. Am J Cancer Res 2012;2(x):xx-xx.
Deng-Shun Wang, et al: DH-PH domain-containing proteins and human cancer. Am J Cancer Res 2012;2(x):xx-xx.
Farbod Shojaei, et al: identification of biomarkers of resistance to angiogenic inhibitors. Am J Cancer Res 2012;2(x):xx-xx.
Monique A. Spillman, et al: ETV4 is differentially regulated by estrogen in breast cancer cells versus ovarian cancer cells. Am J Cancer Res 2012;
2(x):xx-xx.
Vincent Giguère, et al: Estrogen-related receptors in breast cancer: at the crossroad of estrogen and HER-2 signalling. Am J Cancer Res 2012;2
(x):xx-xx.
Simon Saule, et al: Akirin2 increased expression correlates with survival in metastatic uveal melanoma patients. Am J Cancer Res 2012;2(x):xx-
xx.
Aleksander S. Popel, et al: Computational models of antiangiogenic therapies in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Zong Sheng Guo, et al: Cancer epigenetics and therapeutic implications. Am J Cancer Res 2012;2(x):xx-xx.
Hongwu Chen, et al: Epigenetic regulator networks in cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Jaydutt V. Vadgama, et al: Obesity and Breast Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Laura Bracci, et al: Rationale for efficient combination of chemotherapy and immunotherapy against cancer. Am J Cancer Res 2012;2(x):xx-xx.
Jaydutt V. Vadgama, et al: Role of FOXO1A in Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Wenzheng Zhang, et al: Epigenetics of breast cancer and chronic kidney disease. Am J Cancer Res 2012;2(x):xx-xx.
Pranela Rameshwar, et al: AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast
cancer cells. Am J Cancer Res 2012;2(x):xx-xx.
Ben Wielockx, et al: HIF prolyl hydroxylases and their intriguing role during tumor development. Am J Cancer Res 2012;2(x):xx-xx.
Hiroshi Nakagawa, et al: Hypoxia regulates insulin-like growth factor binding protein 3 in esophageal squamous cell carcinoma. Am J Cancer
Res 2012;2(x):xx-xx.
Keiran S. Smalley, et al: Therapeutic targeting of BRAF wild-type melanoma. Am J Cancer Res 2012;2(x):xx-xx.
John Lynch, et al: The role for autophagy in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Am J Cancer Res 2012;2
(x):xx-xx.
Joaquín V. Arribas López, et al: Signaling by HER2 fragments. Am J Cancer Res 2012;2(x):xx-xx.
Wei Xu, et al: Recent advance in protein O-glycosylation in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Rajgopal Govindarajan, et al: Pancreatic cancer chemotherapy: progress and future. Am J Cancer Res 2012;2(x):xx-xx.
Hava Gil-Henn, et al: Invadopodia put the foot in the door. Am J Cancer Res 2012;2(x):xx-xx.
Elizabeth Hopper-Borge, et al: Are ABC transporters relevant to breast cancer? Am J Cancer Res 2012;2(x):xx-xx.
Yun Yen, et al: Salivary gland and clinical management. Am J Cancer Res 2012;2(x):xx-xx.
Li Jiao, et al: Dietary intake and tumor microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Courtney W. Houchen, et al: Comparative evaluation of novel putative stem cell markers and tumor suppressor microRNAs in Barrett’s
esophagus. Am J Cancer Res 2012;2(x):xx-xx.
Bernard S. Lopez, et al: DNA double strand break repair in mammalian cells: competition canonical NHEJ versus Alternative NHEJ;
consequence on genome stability-instability and on radiation therapy strategies. Am J Cancer Res 2012;2(x):xx-xx.
José Courty, et al: Glycoaminoglycans modulate antitumor activity of peudopeptides that target nucleoproteins. Am J Cancer Res 2012;2(x):xx-xx.
Federica Moschella, et al: Immunomodulatory properties of anticancer drugs for improving the efficacy of cancer immunotherapy. Am J Cancer
Res 2012;2(x):xx-xx.
Rosa Marina Melillo, et al: Cancer-related inflammation in thyroid caner. Am J Cancer Res 2012;2(x):xx-xx.
Vijayalakshmi (Viji) Shridhar, et al: Role of endosulfatases HSulf-1 and -2 in women's cancer. Am J Cancer Res 2012;2(x):xx-xx.
Catherine Muller, et al: Stromal Adipocytes : a new component of the tumour microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Cai Weibo, et al: 64Cu-Labeled AApeptides: A new class of PET tracers for cancer imaging. Am J Cancer Res 2012;2(x):xx-xx.
Eran Andrechek, et al: Integrative genomics and breast cancer, a review. Am J Cancer Res 2012;2(x):xx-xx.
Dan Mercola, et al: Should we treat the “stroma” of Prostate Cancer? Am J Cancer Res 2012;2(x):xx-xx.
Calvin P.H. Vary, et al: Proteomic analysis of endoglin-deficient TRAMP prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Bingbing Dai, et al: Molecular mechanism of MEK inhibitor resistance. Am J Cancer Res 2012;2(x):xx-xx.
Jennifer Isaacs, et al: E-cadherin suppression initiates profound genetic and developmental signaling events in prostate cancer. Am J Cancer
Res 2012;2(x):xx-xx.
Leland W. K. Chung, et al: Cell signaling network linking cancer growth and metastasis to the skeleton. Am J Cancer Res 2012;2(x):xx-xx.
Richard Kremer, et al: Parathyroid hormone related protein(PTHrP): biology and targeting strategies. Am J Cancer Res 2012;2(x):xx-xx.
Claudia Lanari, et al: Fibroblast growth factor receptors in breast cancer. A stromal-epithelial connection. Am J Cancer Res 2012;2(x):xx-xx.
Rosana Risques, et al: Senescence-associated markers can distinguish ulcerative colitis patients at risk for cancer progression. Am J Cancer
Res 2012;2(x):xx-xx.
Robert W. Sobol, Jr., et al: Expression profile modulation in DNA Polymerase ß null mouse embryonic fibroblasts. Am J Cancer Res 2012;2(x):xx-
xx.
Shahriar Koochekpour, et al: Prostate cancer biomarkers. Am J Cancer Res 2012;2(x):xx-xx.
Panagiotis A. Konstantinopoulos, et al: The role of oxidative stress in ovarian cancer pathogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Ahmed A Ahmed, et al: Aiming at a moving target: targeting mitosis in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Steven A Johnsen, et al: Cell cycle-dependent regulation of histone mRNA 3’ end processing. Am J Cancer Res 2012;2(x):xx-xx.
Jianxun Song, et al: Development of tumor antigen-specific T lymphocytes from stem cells. Am J Cancer Res 2012;2(x):xx-xx.
Euan Stronach, et al: The DNA damage response to platinum chemotherapy in ovarian cancer. Am J Cancer Res 2012;2(x):xx-xx.
Shiaw-Yih Lin, et al: Replication stress response defects in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Hani Gabra, et al: The role of OPCML and the IgLON family in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Henning Willers, et al: Preclinical modeling of personalized radiation oncology: obstacles and opportunities. Am J Cancer Res 2012;2(x):xx-xx.
Massimo Broggini, et al: K-RAS as a determinant of response to chemotherapy. Am J Cancer Res 2012;2(x):xx-xx.
Anja van de Stolpe, et al: The future of cancer pathology diagnostics – with a focus on CTC-based diagnostics. Am J Cancer Res 2012;2(x):xx-xx.
Joao Taborda Barata, et al: Beyond expression: regulation of PTEN tumor suppressor activity by posttranslational mechanisms that do not
negatively affect PTEN levels. Am J Cancer Res 2012;2(x):xx-xx.
Lu Q. Le, et al: Neurofibromas: cells of origin and the tumor microenvironment. Am J Cancer Res 2012;2(x):xx-xx.
Wafik S. El-Deiry, et al: Novel assay development for biomarker detection on isolated circulating tumor cells. Am J Cancer Res 2012;2(x):xx-xx.
Chun Li, et al: Targeted delivery of nanoparticles targeted to EphB4 receptors. Am J Cancer Res 2012;2(x):xx-xx.
Chris McCabe, et al: Enhancing the sodium iodide symporter in thyroid cancer. Am J Cancer Res 2012;2(x):xx-xx.
Qianben Wang, et al: Role of pioneer transcription factors in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Vasiliki Bravou, et al: Novel insights in colorectal cancer molecular pathogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Seok-Geun Lee, et al: AEG-1 in tumorigenesis of the central nervous system. Am J Cancer Res 2012;2(x):xx-xx.
Suyun Huang, et al: Role of FoxM1 transcription factor in glioblastoma formation and progression. Am J Cancer Res 2012;2(x):xx-xx.
Silvia Deaglio, et al: The tumor microenvironment in chronic lymphocytic leukemia: clues for identifying novel therapeutic targets. Am J Cancer
Res 2012;2(x):xx-xx.
Huafeng Zhang, et al: The role of hypoxia and HIF1 in cancer metastasis. Am J Cancer Res 2012;2(x):xx-xx.
Brandon L Pierce, et al: Unidentified genetic variants influence pancreatic cancer risk: An analysis of the PanScan genome-wide association
study. Am J Cancer Res 2012;2(x):xx-xx.
Tao Zhu, et al: New insight of growth hormone and prolactin in cancer development. Review. Am J Cancer Res 2012;2(x):xx-xx.
Tao Zhu, et al: Gene amplification of growth hormone predict a worse survival outcome in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
Rotem Karni, et al: The role of SR proteins in cancer development and progression. Am J Cancer Res 2012;2(x):xx-xx.
Peng Lee, et al: Androgen receptor and cofactors in prostate cancer. Am J Cancer Res 2012;2(x):xx-xx.
Tokuhiro Chano, et al: RB1CC1 interferes in the crosstalk between autophagy and senescence. Am J Cancer Res 2012;2(x):xx-xx.
Ji-Liang Li, et al: Role of Notch signaling in tumor resistance to anti-cancer therapy. Am J Cancer Res 2012;2(x):xx-xx.
Alberto Izzotti, et al: MicroRNA in lung cancer prevention. Am J Cancer Res 2012;2(x):xx-xx.
Wancai Yang, et al: Molecular mechanisms of dietary factors in colorectal cancer prevention. Am J Cancer Res 2012;2(x):xx-xx.
Frederic Bost, et al: Metformin and Cancer. Am J Cancer Res 2012;2(x):xx-xx.
Santiago Ramón y Cajal Agüeras, et al: Overcoming cellular stress in malignant cells. The role of peIF4E. Am J Cancer Res 2012;2(x):xx-xx.
Alberto Izzotti, et al: MicroRNA in lung cancer prevention. Am J Cancer Res 2012;2(x):xx-xx.
Daolin Tang, et al: Role of autophagy in pancreatic cancer. Am J Cancer Res 2012;2(x):xx-xx.
Katherine A Vallis, et al: The development of radioimmunoconjugates directed against intra-nuclear targets. Am J Cancer Res 2012;2(x):xx-xx.
Lucia Languino, et al: Integrin signaling in cancer progression. Am J Cancer Res 2012;2(x):xx-xx.
Tao Ye, et al: Histone deacetylase inhibitor, largazole, inhibits hepatocellular carcinoma growth both in vitro and in mouse model system. Am J
Cancer Res 2012;2(x):xx-xx.
Andrei Thomas-Tikhonenko, et al: Smad4 inactivation in colon cancer cooperates with deregulation of the Myc oncoprotein to promote tumor
angiogenesis. Am J Cancer Res 2012;2(x):xx-xx.
Xiang-Yang (Shawn) Wang, et al: CD204 represses toll-like receptor agonist elicited antigen-specific antitumor immune response. Am J Cancer
Res 2012;2(x):xx-xx.
Masahisa Jinushi, et al: The regulatory mechanisms of cancer stem cell activities by immunological niche. Am J Cancer Res 2012;2(x):xx-xx.
Jeff Holst, et al: Amino acid transport in cancer. Am J Cancer Res 2012;2(x):xx-xx.
Santosh Kesari, et al: Review of leptomeningeal metastasis in breast cancer. Am J Cancer Res 2012;2(x):xx-xx.
 | |  | |  | |  | |  | |  | |  | |  |
American Journal of Cancer Research
| | | | | | | | | | | | | | |
| ISSN: 2156-6976 |
